Effect of Vitreoretinal Surgery Combined with Platelet-Rich Plasma on the Quality of Life of Patients with Macular Hole
DOI:
https://doi.org/10.56294/hl2025820Keywords:
Macular hole, Pars plana vitrectomy, Internal limiting membrane peel, Platelet-rich plasma, Quality of life, Ophthalmic surgeryAbstract
Introduction: this study evaluates the impact of pars plana vitrectomy (PPV) combined with internal limiting membrane (ILM) peeling and platelet-rich plasma (PRP) application on anatomical, functional, and quality-of-life (QoL) outcomes in patients with macular holes.
Method: prospective cohort study. Tertiary eye care center, January 2021 to December 2023. A total of 155 patients underwent PPV with ILM peeling and PRP. Visual acuity (logMAR), macular hole closure, and QoL were assessed pre- and postoperatively. QoL evaluation used a localized adaptation of the NEI VFQ-25 questionnaire. Anatomical outcomes were measured by Optical Coherence Tomography (OCT).
Results: the mean age was 65,90 ± 8,84 years; 38 % were female. The closure rate was 94 %. Visual acuity improved significantly, with average logMAR improving from 0,7 to 0,3 (p < 0,001). QoL scores improved across all domains: visual functioning increased from 55.3 to 85.7, daily activities from 48,2 to 80,4, and psychological well-being from 50,1 to 82,9. Patients reported greater independence and improved ability in activities like reading, recognizing faces, and participating in sports.
Conclusion: PPV with ILM peeling and PRP is highly effective for macular holes, yielding strong anatomical and functional outcomes alongside significant QoL enhancements.
References
1. Premi E, Donati S, Azzi L, Porta G, Metrangolo C, Fontanel L, Morescalchi F, Azzolini C. Macular Holes: Main Clinical Presentations, Diagnosis, and Therapies. J Ophthalmol. 2022 Apr 11;2022:2270861. doi: 10.1155/2022/2270861. PMID: 35450323; PMCID: PMC9017549.
2. Caporossi T, Carlà MM, Gambini G, De Vico U, Baldascino A, Rizzo S. Spotlight on the Internal Limiting Membrane Technique for Macular Holes: Current Perspectives. Clin Ophthalmol. 2022 Apr 6;16:1069-1084. doi: 10.2147/OPTH.S284620. PMID: 35418741; PMCID: PMC8995173.
3. Zhurgumbayeva G, Kyrykbayev D, Ruslanuly K, Binder S, Kulmaganbetov M. Long-Term Results of Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Vitreomacular Traction Syndrome: A Prospective Investigation in Central Asian Population. Healthcare (Basel). 2024 Dec 30;13(1):44. doi: 10.3390/healthcare13010044. PMID: 39791651; PMCID: PMC11720311.
4. Abdul-Kadir MA, Lim LT. Update on surgical management of complex macular holes: a review. Int J Retina Vitreous. 2021 Dec 20;7(1):75. doi: 10.1186/s40942-021-00350-4. PMID: 34930488; PMCID: PMC8686572.
5. Li Y, Jin S, Shi L, Qin H, Zhao J. Factors Associated with Anatomic Failure and Hole Reopening after Macular Hole Surgery. J Ophthalmol. 2021 Dec 7;2021:7861180. doi: 10.1155/2021/7861180. PMID: 34917414; PMCID: PMC8670966.
6. Yuan D, Zhang W, Yuan S, Xie P, Liu Q. Evaluation of Vision-Related Quality of Life after Autologous Internal Limiting-Membrane Transplantation for Refractory Macular Holes. Clin Ophthalmol. 2020 Jul 23;14:2079-2085. doi: 10.2147/OPTH.S259642. PMID: 32801616; PMCID: PMC7399459.
7. Gurnani B, Kaur K. Comment on “quality of life in patients affected by age-related macular degeneration.” J Clin Ophthalmol Res. 2022;10(1):49. Available from: http://dx.doi.org/10.4103/jcor.jcor_53_21
8. Xu B, Wang Y, Cheng Y, Huang Q. The role of vitreous cortex remnants in secondary macular hole formation and spontaneous closure following vitrectomy for rhegmatogenous retinal detachment. Photodiagnosis Photodyn Ther. 2024 Dec;50:104357. doi: 10.1016/j.pdpdt.2024.104357. Epub 2024 Oct 5. PMID: 39374821.
9. Fayzrakhmanov RR, Pavlovsky OA, Karpov GO. Pathogenetic mechanisms of macular holes: a review of recent research work. Russ Ophthalmol J [Internet]. 2023;16(2):183–7. Available from: http://dx.doi.org/10.21516/2072-0076-2023-16-2-183-187
10. Kassotis A, Ramakrishnan M, Tezel TH. Surgical management of macular holes: techniques, outcomes, and treatment of special cases. Expert Rev Ophthalmol. 2023;18(6):391–403. Available from: http://dx.doi.org/10.1080/17469899.2023.2281447
11. Cyrino FVR, de Lucena MM, de Oliveira Audi L, Filho JARR, Braga JPR, de Azeredo Bastos TM, Coelho IN, Jorge R. Historical and practical aspects of macular buckle surgery in the treatment of myopic tractional maculopathy: case series and literature review. Int J Retina Vitreous. 2024 Aug 28;10(1):60. doi: 10.1186/s40942-024-00578-w. PMID: 39198918; PMCID: PMC11350928.
12. Lin Q, Lim JYC, Xue K, Su X, Loh XJ. Polymeric hydrogels as a vitreous replacement strategy in the eye. Biomaterials. 2021 Jan;268:120547. doi: 10.1016/j.biomaterials.2020.120547. Epub 2020 Nov 24. PMID: 33307366.
13. Pradhan D, Agarwal L, Joshi I, Kushwaha A, Aditya K, Kumari A. Internal limiting membrane peeling in macular hole surgery. Ger Med Sci. 2022 Jun 2;20:Doc07. doi: 10.3205/000309. PMID: 35813123; PMCID: PMC9204259.
14. Wiedemann P. How internal limiting membrane peeling revolutionized macular surgery in the last three decades. Int J Ophthalmol. 2023 Jun 18;16(6):837-840. doi: 10.18240/ijo.2023.06.01. PMID: 37332552; PMCID: PMC10250952.
15. Razavi P, Cakir B, Baldwin G, D'Amico DJ, Miller JB. Heads-Up Three-Dimensional Viewing Systems in Vitreoretinal Surgery: An Updated Perspective. Clin Ophthalmol. 2023 Aug 28;17:2539-2552. doi: 10.2147/OPTH.S424229. PMID: 37662647; PMCID: PMC10473403.
16. Iezzi R, Ferenchak K. Macular Hole Surgery. In: Albert and Jakobiec’s Principles and Practice of Ophthalmology. Cham: Springer International Publishing; 2022. p. 3353–69. doi: 10.1007/978-3-030-42634-7_102
17. Cecerska-Heryć E, Goszka M, Serwin N, Roszak M, Grygorcewicz B, Heryć R, Dołęgowska B. Applications of the regenerative capacity of platelets in modern medicine. Cytokine Growth Factor Rev. 2022 Apr;64:84-94. doi: 10.1016/j.cytogfr.2021.11.003. Epub 2021 Dec 2. PMID: 34924312.
18. Hu T, Zhou T, Goit RK, Tam KC, Chan YK, Lam W-C, et al. Bioactive Glial-Derived Neurotrophic Factor from a Safe Injectable Collagen–Alginate Composite Gel Rescues Retinal Photoreceptors from Retinal Degeneration in Rabbits. Marine Drugs. 2024;22(9):394. doi: 10.3390/md22090394
19. Ricardi F, Gelormini F, Parisi G, Vallino V, Borrelli E, Marolo P, D'Antico S, Salafia M, Reibaldi M. The no-retina-touch technique: vitrectomy and platelet-rich plasma in the treatment of lamellar macular hole. New insights into pathogenesis. Eye (Lond). 2025 Feb;39(2):300-306. doi: 10.1038/s41433-024-03414-5. Epub 2024 Oct 24. PMID: 39448851; PMCID: PMC11751382.
20. Hagenau F, Nobl M, Vogt D, Schworm B, Siedlecki J, Kreutzer T, Luft N, Priglinger S. Highly Concentrated Autologous Platelet-Rich Plasma Restores Foveal Anatomy in Lamellar Macular Hole Surgery. Klin Monbl Augenheilkd. 2021 Aug;238(8):885-892. English. doi: 10.1055/a-1409-9268. Epub 2021 May 17. PMID: 34000748.
21. Sadeghi E, Mohan S, Iannetta D, Chhablani J. Recent developments in imaging and surgical vision technologies currently available for improving vitreoretinal surgery: a narrative review. Expert Rev Med Devices. 2023 Jul-Dec;20(8):651-672. doi: 10.1080/17434440.2023.2231841. Epub 2023 Jul 6. PMID: 37394991.
22. Johansson LH, Kalaboukhova L, Erhag HF, Skoog I, Zetterberg M. Vision-related quality of life among 70-year-olds diagnosed with glaucoma. Acta Ophthalmol. 2024 Mar;102(2):201-207. doi: 10.1111/aos.15737. Epub 2023 Aug 2. PMID: 37533157.
23. Wang MC, Bellows J. Quality of life and patient-centered outcomes. In: Chronic Illness Care. Cham: Springer International Publishing; 2018. p. 95–107. doi: 10.1007/978-3-319-71812-5_8
24. Michalewska Z, Michalewski J, Dulczewska-Cichecka K, Nawrocki J. Inverted internal limiting membrane flap technique for surgical repair of myopic macular holes. Retina. 2014;34(4):664–9. Available from: http://dx.doi.org/10.1097/IAE.0000000000000042
25. Scott IU, Moraczewski AL, Smiddy WE, Flynn HW Jr, Feuer WJ. Long-term anatomic and visual acuity outcomes after initial anatomic success with macular hole surgery. Am J Ophthalmol. 2003;135(5):633–40. Available from: http://dx.doi.org/10.1016/s0002-9394(02)02240-7
26. Ezra E, Fariss RN, Possin DE, Aylward WG, Gregor ZJ, Luthert PJ, Milam AH. Immunocytochemical characterization of macular hole opercula. Arch Ophthalmol. 2001 Feb;119(2):223-31. PMID: 11176983.
27. Hirneiss C, Neubauer AS, Gass CA, Reiniger IW, Priglinger SG, Kampik A, et al. Visual quality of life after macular hole surgery: outcome and predictive factors. Br J Ophthalmol. 2007;91(4):481–4. Available from: http://dx.doi.org/10.1136/bjo.2006.102376
28. Neffendorf JE, Gupta B, Williamson TH. Intraoperative complications of patients undergoing small-gauge and 20-gauge vitrectomy: a database study of 4,274 procedures. Eur J Ophthalmol. 2017;27(2):226–30. Available from: http://dx.doi.org/10.5301/ejo.5000856
29. Zheng C, Zhu Q, Liu X, Huang X, He C, Jiang L, Quan D, Zhou X, Zhu Z. Effect of platelet-rich plasma (PRP) concentration on proliferation, neurotrophic function and migration of Schwann cells in vitro. J Tissue Eng Regen Med. 2016 May;10(5):428-36. doi: 10.1002/term.1756. Epub 2013 May 31. PMID: 23723151.
30. Govbakh I, Kyryk V, Ustymenko A, Rubtsov V, Tsupykov O, Bulgakova NV, Zavodovskiy DO, Sokolowska I, Maznychenko A. Stem Cell Therapy Enhances Motor Activity of Triceps Surae Muscle in Mice with Hereditary Peripheral Neuropathy. Int J Mol Sci. 2021 Nov 6;22(21):12026. Available from: https://doi.org/10.3390/ijms222112026.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Dastan Kyrykbayev (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
